ELTX · Elicio Therapeutics, Inc. · Investor Relations
$2.05
-0.06 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Aug 13, 2026
Market Cap
$53.88M
Shares
26.28M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-24 | Elicio Therapeutics Virtual KOL Event to Discuss Multiple Complete Responses after ELI-002 7P Treatment | Event |
| 2026-06-15 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-15 | June 15th Conference Call | Conference |
| 2026-05-14 | Bank of America Health Care Conference | Conference |
| 2026-03-04 | TD Cowen 46th Annual Health Care Conference | Conference |
Source: https://elicio.com/investors/
Key facts
CIK
1601485
CUSIP
28657F103
13F (30d)
19 filings
19 filers
Visit website
Investor relations